Editorial (Hot Topic: The Importance of Rational Chemotherapy of Chronic Lymphocytic Leukemia)

E-ISSN： 1873-4286|18|23|3321-3322

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.23, 2012-08, pp. : 3321-3322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Advances in Rational Drug Design)

Current Pharmaceutical Design, Vol. 19, Iss. 26, 2013-08 ,pp. : 4673-4673

Bentham Science Publishers

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

Microenvironmental Interactions in Chronic Lymphocytic Leukemia: Hints for Pathogenesis and Identification of Targets for Rational Therapy

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3323-3334

Bentham Science Publishers

Access to resources Recommend Favorite

Bendamustine for treatment of chronic lymphocytic leukemia

By Chang Julie Elizabeth Kahl Brad Steven

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide in lymphomas and chronic lymphocytic leukemia

By Wiernik Peter H

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 4, 2013-03 ,pp. : 475-488

Informa Healthcare

Access to resources Recommend Favorite